RxDoctor Payments Data

Lawrence Coss, MD

Family Medicine · Snowflake, AZNPI 1932171311

Payments from drug & device makers

$1,562in general payments, 2019–2025

Across 94 payments — averaging $16.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$423
  • AstraZeneca$270
  • Novo Nordisk$172
  • Lilly USA, LLC$130
  • Xeris Pharmaceuticals, Inc.$101
  • Grifols USA, LLC$75
  • plus $391 from 15 others

What the payments were for

  • Speaking & faculty fees$181%
  • Food & beverage$1,54499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,562 in reported general payments places this provider in the 75th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$1,215
Medicare patients
55
Services billed
86

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban142$144,203
TrulicityDulaglutide30$30,354
OzempicSemaglutide14$20,046
FarxigaDapagliflozin Propanediol15$16,127
Bydureon BciseExenatide Microspheres12$9,629
XareltoRivaroxaban11$6,095
Breo ElliptaFluticasone/Vilanterol12$5,439
Atorvastatin Calcium388$3,920
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,856
SynthroidLevothyroxine Sodium45$2,788
Levothyroxine Sodium285$2,409
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$2,398
Losartan Potassium228$2,382
Pantoprazole Sodium211$2,142
Metoprolol Succinate157$1,842

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$423$144,203142 claims
Lilly USA, LLCTrulicity$130$30,35430 claims
Novo NordiskOzempic$172$20,04614 claims
AstraZenecaFarxiga$270$16,12715 claims
Johnson & JohnsonXarelto$13$6,09511 claims
GSKBreo Ellipta$30$5,43912 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Snowflake

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →